Outlook Therapeutics (OTLK) Inventory (2024 - 2026)
Outlook Therapeutics (OTLK) posted quarterly Inventory of $3.3 million for Q1 2026, down 7.22% year-over-year from $3.6 million in Q1 2025, and down 3.29% quarter-over-quarter from $3.5 million in Q4 2025.
Outlook Therapeutics (OTLK) Inventory (2024 - 2026) Analysis & Trends
Outlook Therapeutics (OTLK) has reported Inventory for 3 consecutive years, with $3.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory fell 7.22% year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $3.3 million (down 7.22% YoY), while the FY2025 annual figure was $3.3 million, changed N/A from the prior year.
- Inventory declined to $3.3 million in Q1 2026 per OTLK's latest filing, from $3.5 million in the prior quarter.
- Across five years, Inventory topped out at $4.1 million in Q2 2025 and bottomed at $3.1 million in Q4 2024.
- Historically, Inventory has averaged $3.5 million across 3 years, with a median of $3.4 million in 2025.
- Annual changes were most pronounced in 2025 — Inventory rose 11.21% — and 2026, when it decreased 7.22%.
- Outlook Therapeutics' Inventory stood at $3.1 million in 2024, then climbed by 11.21% to $3.5 million in 2025, then dropped by 3.29% to $3.3 million in 2026.
- Business Quant data shows OTLK's Inventory at $3.3 million in Q1 2026, $3.5 million in Q4 2025, and $3.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 97.11 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 142.38 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 128.86 Mn |
| 10 | Outlook Therapeutics | 93.64 Mn | 82.40 Mn | -8,265.00 | 5.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.34 Mn |
| Dec 31, 2025 | 3.46 Mn |
| Sep 30, 2025 | 3.34 Mn |
| Jun 30, 2025 | 4.13 Mn |
| Mar 31, 2025 | 3.60 Mn |
| Dec 31, 2024 | 3.11 Mn |